Literature DB >> 27002925

Long-term neuropathological and behavioral impairments after exposure to nerve agents.

Vassiliki Aroniadou-Anderjaska1,2, Taiza H Figueiredo1, James P Apland3, Eric M Prager1, Volodymyr I Pidoplichko1, Steven L Miller1, Maria F M Braga1,2.   

Abstract

One of the deleterious effects of acute nerve agent exposure is the induction of status epilepticus (SE). If SE is not controlled effectively, it causes extensive brain damage. Here, we review the neuropathology observed after nerve agent-induced SE, as well as the ensuing pathophysiological, neurological, and behavioral alterations, with an emphasis on their time course and longevity. Limbic structures are particularly vulnerable to damage by nerve agent exposure. The basolateral amygdala (BLA), which appears to be a key site for seizure initiation upon exposure, suffers severe neuronal loss; however, GABAergic BLA interneurons display a delayed death, perhaps providing a window of opportunity for rescuing intervention. The end result is a long-term reduction of GABAergic activity in the BLA, with a concomitant increase in spontaneous excitatory activity; such pathophysiological alterations are not observed in the CA1 hippocampal area, despite the extensive neuronal loss. Hyperexcitability in the BLA may be at least in part responsible for the development of recurrent seizures and increased anxiety, while hippocampal damage may underlie the long-term memory impairments. Effective control of SE after nerve agent exposure, such that brain damage is also minimized, is paramount for preventing lasting neurological and behavioral deficits.
© 2016 New York Academy of Sciences.

Entities:  

Keywords:  anxiety; basolateral amygdala; hippocampus; nerve agents; seizures; status epilepticus

Mesh:

Substances:

Year:  2016        PMID: 27002925      PMCID: PMC4940270          DOI: 10.1111/nyas.13028

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  74 in total

1.  Selective reduction in amygdala volume in pediatric anxiety disorders: a voxel-based morphometry investigation.

Authors:  Michael P Milham; Allison C Nugent; Wayne C Drevets; Daniel P Dickstein; Ellen Leibenluft; Monique Ernst; Dennis Charney; Daniel S Pine
Journal:  Biol Psychiatry       Date:  2005-05-01       Impact factor: 13.382

2.  The model of pentylenetetrazol-induced status epilepticus in the immature rat: short- and long-term effects.

Authors:  A Nehlig; A Pereira de Vasconcelos
Journal:  Epilepsy Res       Date:  1996-12       Impact factor: 3.045

3.  Post-traumatic stress disorder symptoms in victims of Tokyo subway attack: a 5-year follow-up study.

Authors:  Toshiyuki Ohtani; Akira Iwanami; Kiyoto Kasai; Hidenori Yamasue; Tadafumi Kato; Tsukasa Sasaki; Nobumasa Kato
Journal:  Psychiatry Clin Neurosci       Date:  2004-12       Impact factor: 5.188

Review 4.  Experimental studies in epilepsy: immunologic and inflammatory mechanisms.

Authors:  Agustín Legido; Christos D Katsetos
Journal:  Semin Pediatr Neurol       Date:  2014-10-13       Impact factor: 1.636

5.  Long-term effects of cytokine treatment on cognitive behavioral recovery and neuronal regeneration in soman-poisoned mice.

Authors:  Jean-Marc Collombet; Daniel Béracochéa; Pierrette Liscia; Christophe Piérard; Guy Lallement; Pierre Filliat
Journal:  Behav Brain Res       Date:  2011-03-10       Impact factor: 3.332

6.  Magnetic resonance imaging reveals that galantamine prevents structural brain damage induced by an acute exposure of guinea pigs to soman.

Authors:  Rao P Gullapalli; Yasco Aracava; Jiachen Zhuo; Edward Helal Neto; Jiazheng Wang; George Makris; Istvan Merchenthaler; Edna F R Pereira; Edson X Albuquerque
Journal:  Neurotoxicology       Date:  2009-09-24       Impact factor: 4.294

7.  ASIC1a activation enhances inhibition in the basolateral amygdala and reduces anxiety.

Authors:  Volodymyr I Pidoplichko; Vassiliki Aroniadou-Anderjaska; Eric M Prager; Taiza H Figueiredo; Camila P Almeida-Suhett; Steven L Miller; Maria F M Braga
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

8.  Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting.

Authors:  L E Mello; E A Cavalheiro; A M Tan; W R Kupfer; J K Pretorius; T L Babb; D M Finch
Journal:  Epilepsia       Date:  1993 Nov-Dec       Impact factor: 5.864

9.  Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.

Authors:  M Ankarcrona; J M Dypbukt; E Bonfoco; B Zhivotovsky; S Orrenius; S A Lipton; P Nicotera
Journal:  Neuron       Date:  1995-10       Impact factor: 17.173

10.  Up-regulation of D-serine might induce GABAergic neuronal degeneration in the cerebral cortex and hippocampus in the mouse pilocarpine model of epilepsy.

Authors:  Yong-Hong Liu; Lian Wang; Li-Chun Wei; Yuan-Gui Huang; Liang-Wei Chen
Journal:  Neurochem Res       Date:  2009-01-03       Impact factor: 3.996

View more
  18 in total

1.  Novel Brain-Penetrating Oxime Acetylcholinesterase Reactivators Attenuate Organophosphate-Induced Neuropathology in the Rat Hippocampus.

Authors:  Mary B Dail; Charles A Leach; Edward C Meek; Alicia K Olivier; Ronald B Pringle; Carol E Green; Janice E Chambers
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

Review 2.  Novel centrally active oxime reactivators of acetylcholinesterase inhibited by surrogates of sarin and VX.

Authors:  Janice E Chambers; Edward C Meek
Journal:  Neurobiol Dis       Date:  2019-05-31       Impact factor: 5.996

3.  Age-Related Susceptibility to Epileptogenesis and Neuronal Loss in Male Fischer Rats Exposed to Soman and Treated With Medical Countermeasures.

Authors:  Brenda Marrero-Rosado; Franco Rossetti; Matthew W Rice; Mark C Moffett; Robyn B Lee; Michael F Stone; Lucille A Lumley
Journal:  Toxicol Sci       Date:  2018-07-01       Impact factor: 4.849

4.  Diapocynin, an NADPH oxidase inhibitor, counteracts diisopropylfluorophosphate-induced long-term neurotoxicity in the rat model.

Authors:  Marson Putra; Meghan Gage; Shaunik Sharma; Cara Gardner; Grace Gasser; Vellareddy Anantharam; Thimmasettappa Thippeswamy
Journal:  Ann N Y Acad Sci       Date:  2020-02-10       Impact factor: 5.691

5.  Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Volodymyr I Pidoplichko; Katia Rossetti; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2018-02-21       Impact factor: 4.030

6.  TSPO PET Using [18F]PBR111 Reveals Persistent Neuroinflammation Following Acute Diisopropylfluorophosphate Intoxication in the Rat.

Authors:  Brad A Hobson; Douglas J Rowland; Sílvia Sisó; Michelle A Guignet; Zachary T Harmany; Suren B Bandara; Naomi Saito; Danielle J Harvey; Donald A Bruun; Joel R Garbow; Abhijit J Chaudhari; Pamela J Lein
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

Review 7.  Oxime-mediated reactivation of organophosphate-inhibited acetylcholinesterase with emphasis on centrally-active oximes.

Authors:  Janice E Chambers; Mary B Dail; Edward C Meek
Journal:  Neuropharmacology       Date:  2020-06-13       Impact factor: 5.250

8.  Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Marcio De Araujo Furtado; Maria F M Braga
Journal:  Neurotox Res       Date:  2018-04-30       Impact factor: 3.911

Review 9.  Central neuroprotection demonstrated by novel oxime countermeasures to nerve agent surrogates.

Authors:  Janice E Chambers; Edward C Meek
Journal:  Ann N Y Acad Sci       Date:  2020-04-21       Impact factor: 6.499

10.  In Vitro Evaluation of Neutral Aryloximes as Reactivators for Electrophorus eel Acetylcholinesterase Inhibited by Paraoxon.

Authors:  Daniel A S Kitagawa; Samir F de A Cavalcante; Reuel L de Paula; Rafael B Rodrigues; Leandro B Bernardo; Munique C J da Silva; Thiago N da Silva; Wellington V Dos Santos; José M Granjeiro; Joyce S F D de Almeida; Marcos C Barcellos; Ana Beatriz de A Correa; Tanos C C França; Kamil Kuča; Alessandro B C Simas
Journal:  Biomolecules       Date:  2019-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.